Clinical Trial Update: Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety and tolerability trial of EG-1962 in patients with aneurysmal subarachnoid hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ruptured Berry Aneurysm
• Ruptured Cerebral Aneurysm

Drugs mentioned

• EG-1962

Snippet

Sponsor: Edge Therapeutics Inc | Conditions: Ruptured Cerebral Aneurysm, Ruptured Berry Aneurysm | Phase 1, Phase 2 | Status: COMPLETED